Company intelligence / Profile preview

CognoGen Biotechnology Consulting

Sarasota, Florida, United Statesbrandbucket.com ↗

Ownership: Private
Development stage: Other

Overview

CognoGen Biotechnology Consulting is a life science consultancy founded by Dr. Richard H. Baltz after his retirement from Eli Lilly in 1998, providing expert advice to biotechnology and pharmaceutical companies[1][6]. The company does not have its own clinical pipeline but offers strategic guidance and scientific expertise to industry clients.

Industry: Consulting

Partnerships

No major partnerships publicly listed; operates primarily as an independent consultancy.

Beyond the preview

Go deeper on CognoGen Biotechnology Consulting.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CognoGen Biotechnology Consulting.

Explore the full profile